K-V Investors Can't Save Suit Over Pregnancy Drug
A Missouri federal judge on Friday dismissed K-V Pharmaceutical Co. investors' consolidated securities fraud class action accusing the company of lying about prospects for pregnancy drug Makena, artificially inflating the stock...To view the full article, register now.
Already a subscriber? Click here to view full article